Correlation Between Tscan Therapeutics and TRACON Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and TRACON Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and TRACON Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and TRACON Pharmaceuticals, you can compare the effects of market volatilities on Tscan Therapeutics and TRACON Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of TRACON Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and TRACON Pharmaceuticals.
Diversification Opportunities for Tscan Therapeutics and TRACON Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tscan and TRACON is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and TRACON Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TRACON Pharmaceuticals and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with TRACON Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TRACON Pharmaceuticals has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and TRACON Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and TRACON Pharmaceuticals
Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the TRACON Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Tscan Therapeutics is 1.85 times less risky than TRACON Pharmaceuticals. The stock trades about -0.12 of its potential returns per unit of risk. The TRACON Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 182.00 in TRACON Pharmaceuticals on November 3, 2024 and sell it today you would lose (22.00) from holding TRACON Pharmaceuticals or give up 12.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 20.43% |
| Values | Daily Returns |
Tscan Therapeutics vs. TRACON Pharmaceuticals
Performance |
| Timeline |
| Tscan Therapeutics |
| TRACON Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tscan Therapeutics and TRACON Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and TRACON Pharmaceuticals
The main advantage of trading using opposite Tscan Therapeutics and TRACON Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, TRACON Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will offset losses from the drop in TRACON Pharmaceuticals' long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| TRACON Pharmaceuticals vs. Rezolute | TRACON Pharmaceuticals vs. XOMA Corp | TRACON Pharmaceuticals vs. Vincerx Pharma | TRACON Pharmaceuticals vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |